The ability of pGz to enhance the expression of eNOS, p-eNOS, and nNOS and to reduce iNOS in the skeletal muscle of db/db mice suggests that it may hold therapeutic potential for the management of patients with T2D. The gene discussed is NOS3; the disease is type 2 diabetes mellitus.